JP2014530882A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530882A5 JP2014530882A5 JP2014537380A JP2014537380A JP2014530882A5 JP 2014530882 A5 JP2014530882 A5 JP 2014530882A5 JP 2014537380 A JP2014537380 A JP 2014537380A JP 2014537380 A JP2014537380 A JP 2014537380A JP 2014530882 A5 JP2014530882 A5 JP 2014530882A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- hydrogen
- group
- structural formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161550610P | 2011-10-24 | 2011-10-24 | |
| US61/550,610 | 2011-10-24 | ||
| PCT/US2012/061737 WO2013063149A1 (en) | 2011-10-24 | 2012-10-24 | Sialic acid analogs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014530882A JP2014530882A (ja) | 2014-11-20 |
| JP2014530882A5 true JP2014530882A5 (https=) | 2015-09-10 |
| JP6196224B2 JP6196224B2 (ja) | 2017-09-13 |
Family
ID=48168447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537380A Active JP6196224B2 (ja) | 2011-10-24 | 2012-10-24 | シアル酸類似体 |
Country Status (13)
| Country | Link |
|---|---|
| US (5) | US8840926B2 (https=) |
| EP (1) | EP2771348B1 (https=) |
| JP (1) | JP6196224B2 (https=) |
| KR (1) | KR102049214B1 (https=) |
| CN (1) | CN103974965B (https=) |
| AU (1) | AU2012328874B2 (https=) |
| BR (1) | BR112014009760B1 (https=) |
| CA (1) | CA2849114C (https=) |
| ES (1) | ES2807890T3 (https=) |
| HK (1) | HK1201067A1 (https=) |
| IL (1) | IL231714B (https=) |
| MX (1) | MX347541B (https=) |
| WO (1) | WO2013063149A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9241896B2 (en) | 2008-12-19 | 2016-01-26 | Ultragenyx Pharmaceutical Inc. | Methods and formulations for treating sialic acid deficiencies |
| CA2805222A1 (en) | 2010-07-13 | 2012-01-19 | Ultragenyx Pharmaceutical Inc. | Methods and formulations for treating sialic acid deficiencies |
| HK1201067A1 (en) | 2011-10-24 | 2015-08-21 | 罕见病药物研发公司 | Sialic acid analogs |
| CA2862836A1 (en) * | 2012-01-18 | 2013-07-25 | Ultragenyx Pharmaceutical Inc. | Methods and formulations for treating sialic acid deficiencies |
| US10385085B2 (en) | 2015-09-14 | 2019-08-20 | Ultragenyx Pharmaceutical Inc. | Crystal forms of sialic acid or salt or solvate thereof |
| WO2024173797A1 (en) * | 2023-02-17 | 2024-08-22 | Ultragenyx Pharmaceutical Inc. | Crystalline forms of sialic acid derivatives and methods for their use |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6168418A (ja) | 1984-09-11 | 1986-04-08 | Kanto Ishi Pharma Co Ltd | 去痰薬 |
| JPS63139193A (ja) * | 1986-11-28 | 1988-06-10 | Mect Corp | シアル酸誘導体１，７−ラクトン |
| US6156544A (en) | 1993-06-09 | 2000-12-05 | Glaxo Group Limited | Process for the preparation of N-acetylneuraminic acid |
| EP0820305A2 (en) | 1995-04-04 | 1998-01-28 | Wound Healing of Oklahoma | Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant |
| US5624677A (en) | 1995-06-13 | 1997-04-29 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
| WO1999052931A1 (fr) | 1998-04-10 | 1999-10-21 | Mitsubishi Chemical Corporation | Dispersion solide contenant un derive d'acide sialique |
| KR20030006721A (ko) | 2001-07-14 | 2003-01-23 | 삼성전자 주식회사 | 리소그라피 시스템 및 이를 이용한 레티클 표면의 파티클제거방법 |
| RU2362807C2 (ru) | 2002-06-21 | 2009-07-27 | Ново Нордиск Хелт Кэр Аг | Конъюгат полипептида фактора vii, способ его получения, его применение и содержащая его фармацевтическая композиция |
| US7238677B2 (en) | 2003-03-28 | 2007-07-03 | Kimberly-Clark Worldwide, Inc. | Prevention of urogenital infections |
| US20050201974A1 (en) * | 2003-12-09 | 2005-09-15 | Spherics, Inc. | Bioadhesive polymers with catechol functionality |
| WO2006096161A1 (en) | 2005-03-03 | 2006-09-14 | Mannatech, Inc. | Methods and compositions for modified release of nutritional supplements |
| WO2007103286A2 (en) * | 2006-03-02 | 2007-09-13 | Spherics, Inc. | Rate-controlled bioadhesive oral dosage formulations |
| WO2008027557A2 (en) * | 2006-08-31 | 2008-03-06 | Spherics, Inc. | Topiramate compositions and methods of enhancing its bioavailability |
| EP2155207A2 (en) | 2007-05-31 | 2010-02-24 | Government Of The United States Of America As Represented by Secretary of the Dep. of Health and Human Services National Institute of Health | N-acetyl mannosamine as a therapeutic agent |
| WO2009032605A2 (en) | 2007-08-27 | 2009-03-12 | Massachusetts Institute Of Technology | Bi-functional polymer-attached inhibitors of influenza virus |
| CN102316730A (zh) | 2008-05-09 | 2012-01-11 | 天雅瑞药业有限公司 | 用于减轻全身性炎症和/或血管炎症的n-乙酰半胱氨酸(nac)的控释 |
| KR101116864B1 (ko) | 2008-08-01 | 2012-02-29 | 주식회사 베네비오 | 고지혈증, 지방간 또는 비만의 예방 또는 치료용 조성물 |
| US9241896B2 (en) | 2008-12-19 | 2016-01-26 | Ultragenyx Pharmaceutical Inc. | Methods and formulations for treating sialic acid deficiencies |
| US20100159001A1 (en) | 2008-12-19 | 2010-06-24 | Cardinal John R | Extended-Release Pharmaceutical Formulations |
| US20100160363A1 (en) | 2008-12-19 | 2010-06-24 | Aaipharma Services Corp. | Extended-release pharmaceutical formulations |
| CN102427817B (zh) | 2009-05-15 | 2015-02-11 | 财团法人日本健康科学振兴财团 | 起因于gne蛋白质功能降低的疾病的治疗用药物、食品组合物、食品添加剂 |
| CA2805222A1 (en) | 2010-07-13 | 2012-01-19 | Ultragenyx Pharmaceutical Inc. | Methods and formulations for treating sialic acid deficiencies |
| HK1201067A1 (en) | 2011-10-24 | 2015-08-21 | 罕见病药物研发公司 | Sialic acid analogs |
| CA2862836A1 (en) | 2012-01-18 | 2013-07-25 | Ultragenyx Pharmaceutical Inc. | Methods and formulations for treating sialic acid deficiencies |
| JP6671305B2 (ja) | 2015-01-28 | 2020-03-25 | 協和発酵バイオ株式会社 | Ｎ−アセチルノイラミン酸アンモニウム塩・無水和物の結晶及びその製造方法 |
| US10385085B2 (en) | 2015-09-14 | 2019-08-20 | Ultragenyx Pharmaceutical Inc. | Crystal forms of sialic acid or salt or solvate thereof |
-
2012
- 2012-10-24 HK HK15101526.4A patent/HK1201067A1/xx unknown
- 2012-10-24 US US13/659,550 patent/US8840926B2/en active Active
- 2012-10-24 AU AU2012328874A patent/AU2012328874B2/en active Active
- 2012-10-24 MX MX2014004928A patent/MX347541B/es active IP Right Grant
- 2012-10-24 CA CA2849114A patent/CA2849114C/en active Active
- 2012-10-24 JP JP2014537380A patent/JP6196224B2/ja active Active
- 2012-10-24 BR BR112014009760-7A patent/BR112014009760B1/pt active IP Right Grant
- 2012-10-24 EP EP12843460.2A patent/EP2771348B1/en active Active
- 2012-10-24 CN CN201280052218.0A patent/CN103974965B/zh active Active
- 2012-10-24 ES ES12843460T patent/ES2807890T3/es active Active
- 2012-10-24 WO PCT/US2012/061737 patent/WO2013063149A1/en not_active Ceased
- 2012-10-24 KR KR1020147013997A patent/KR102049214B1/ko active Active
-
2014
- 2014-03-26 IL IL231714A patent/IL231714B/en active IP Right Grant
- 2014-08-15 US US14/461,295 patent/US9221858B2/en active Active
-
2015
- 2015-11-18 US US14/944,779 patent/US10065981B2/en active Active
-
2018
- 2018-07-31 US US16/050,343 patent/US10457701B2/en active Active
-
2019
- 2019-09-16 US US16/571,589 patent/US10889607B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102666477B1 (ko) | 글루타민 유사체의 프로드럭 | |
| ES2970715T3 (es) | Composiciones y métodos para inhibir la actividad de la arginasa | |
| JP2014530882A5 (https=) | ||
| CN113423685A (zh) | 整合应激通路的前药调节剂 | |
| ES2694328T3 (es) | Composición acuosa líquida | |
| WO2019110773A1 (fr) | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes | |
| AR064304A1 (es) | Formulaciones de ansamicina y sus metodos de uso | |
| RU2012108874A (ru) | Композиции, содержащие расщепляемые ферментами опиоидные пролекарства с модифицированным кетоном и их дополнительные ингибиторы | |
| EP3740229A1 (fr) | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes | |
| JP7650228B2 (ja) | 官能化シクロオクテンを調製するためのプロセス | |
| WO2019110837A1 (fr) | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide | |
| JP2019503356A5 (https=) | ||
| JP2018527360A (ja) | 修飾された細胞毒とその治療的使用 | |
| JP7376694B2 (ja) | 再生可能資源に由来するポリマーおよび組成物 | |
| WO2016136641A1 (ja) | 生理活性物質結合ブロック共重合体 | |
| JP2021534162A (ja) | 癌を処置する方法に用いられるコンジュゲート | |
| ES2884123T3 (es) | Formulaciones de inhibidores de xantina oxidasa | |
| BR112020011484A2 (pt) | composições na forma de uma solução aquática injetável compreendendo glucagon humano e um co-poliaminoácido | |
| WO2021127452A1 (en) | Compounds for the treatment of bacterial infections and potentiation of antibiotics | |
| KR20220005554A (ko) | 전구약물 화합물 | |
| CN113365617B (zh) | 用于医学疾病治疗的一氧化碳前药 | |
| EP3378495B1 (en) | Composition comprising novel glutamic acid derivative and block copolymer, and use thereof | |
| JP7506660B2 (ja) | デンドリマー製剤 | |
| ITMI20120121A1 (it) | Nuovi composti antitumorali | |
| JP6454030B2 (ja) | ペプチドホウ酸化合物を含有する安定化薬学製剤 |